<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05055154</url>
  </required_header>
  <id_info>
    <org_study_id>OSMN35aVLCD-26</org_study_id>
    <nct_id>NCT05055154</nct_id>
  </id_info>
  <brief_title>Oxidative Stress and L-CBMN Cytome Assay in Obese After 3 Weeks VLCD</brief_title>
  <official_title>Oxidative Stress and L-CBMN Cytome Assay Parameters Levels in Severely Obese With BMI ≥ 35kg/m2 After 3 Weeks 567 kcal Hospital Controlled VLCD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Special Hospital for Extended Treatment of Duga Resa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for Medical Research and Occupational Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Zagreb</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Special Hospital for Extended Treatment of Duga Resa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity leads to physiological imbalance resulting in hyperglycemia, dyslipidaemia and&#xD;
      inflammation and can generate systematic oxidative stress through multiple biochemical&#xD;
      mechanisms. Oxidative stress (OS) can induce DNA damage and inhibit DNA repair mechanisms.&#xD;
      Very low calorie diet (VLCD) have rapid positive effect on weight loss, glucose homeostasis,&#xD;
      insulin resistance, inflammation and OS. The aim of this study is to determine the effect of&#xD;
      a three-week VLCD on anthropometric, biochemical and genomic parameters in individuals with&#xD;
      BMI ≥ 35kg/m2.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity is a complex chronic multifactorial disease associated with concomitant or increased&#xD;
      risk for chronic inflammation, insulin resistance, dyslipidemia, oxidative stress, type 2&#xD;
      diabetes, cardiovascular disease, stroke and multiple cancer types. Oxidative stress (OS) can&#xD;
      cause permanent DNA damage which could be detected with lymphocytes cytokinesis-block&#xD;
      micronucleus (L-CBMN) cytome assay. Weight loss and improvement of dietary habits in people&#xD;
      with obesity can affect genome stability and have beneficial effects on insulin sensitivity,&#xD;
      inflammation and OS. Effects of very low calorie diet (VLCD) on DNA damage are scarce. The&#xD;
      aim of this study is to determine the effect of a three-week VLCD used in Special Hospital&#xD;
      for extended treatment of Duga Resa in patients with BMI ≥ 35kg/m2 on permanent DNA damage,&#xD;
      lipid profile, insulin resistance, inflammation and anthropometric parameters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 14, 2019</start_date>
  <completion_date type="Actual">November 3, 2020</completion_date>
  <primary_completion_date type="Actual">November 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The changes in body mass index</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Body mass index is calculated by dividing body mass (kg) with square of body height (m)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in the body fat mass</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Body fat mass (kg) assessed with bioelectrical impedance method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in the skeletal muscle mass</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Skeletal muscle mass (kg) assessed with bioelectrical impedance method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in the percent body fat</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Percent body fat (%) assessed with bioelectrical impedance method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in fasting glucose concentration</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Concentration of glucose (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in urea concentration</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Concentration of urea (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in lipid profile</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Concentrations of triglycerides (mmo/L), LDL (mmol/L), HDL (mmol/L) cholesterol (mmol/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in insulin concentration</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Concentration of insulin (mIU/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in homeostatic model assessment (HOMA) index</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>HOMA index is calculated according to the following formula: glucose (mmol/L) x insulin (mIU/L)/22.5</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The changes in inflammation parameters</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Concentration of C-reactive protein (mg/L) and total white blood cell count</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The changes in oxidative stress</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Concentration of glutathione (RFU) and reactive oxygen species (RFU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes in DNA damage</measure>
    <time_frame>Baseline, after 3 weeks of VLCD</time_frame>
    <description>Frequency of micronucleus, nuclear buds, nucleoplasmic bridges, apoptotic and necrotic cells among 1000 lymphocytes</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Obesity</condition>
  <condition>Weight Loss</condition>
  <condition>DNA Damage</condition>
  <arm_group>
    <arm_group_label>Very low calorie diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of very low calorie diet prepared in the hospital</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Very low calorie diet</intervention_name>
    <description>In hospital patients will eat prepared diet with 567 kcal a day during 3 weeks</description>
    <arm_group_label>Very low calorie diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  body mass index ≥ 35 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  actual tumor diseases&#xD;
&#xD;
          -  recent diagnostic or treatment exposures to ionizing radiation in the period of one&#xD;
             year&#xD;
&#xD;
          -  individuals not willing to stay 3 weeks under supervision under full 24 h surveillance&#xD;
             from the medical stuff&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mirta Milic, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Medical Research and Occupational Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dragan Bozcevic, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Special Hospital for Extended Treatment of Duga Resa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana-Marija Domijan, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zagreb</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Special Hospital for Extended Treatment of Duga Resa</name>
      <address>
        <city>Duga Resa</city>
        <zip>47250</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Grindel A, Brath H, Nersesyan A, Knasmueller S, Wagner KH. Association of Genomic Instability with HbA1c levels and Medication in Diabetic Patients. Sci Rep. 2017 Feb 2;7:41985. doi: 10.1038/srep41985.</citation>
    <PMID>28150817</PMID>
  </reference>
  <reference>
    <citation>Franzke B, Schwingshackl L, Wagner KH. Chromosomal damage measured by the cytokinesis block micronucleus cytome assay in diabetes and obesity - A systematic review and meta-analysis. Mutat Res Rev Mutat Res. 2020 Oct - Dec;786:108343. doi: 10.1016/j.mrrev.2020.108343. Epub 2020 Nov 2.</citation>
    <PMID>33339574</PMID>
  </reference>
  <reference>
    <citation>Mulligan AA, Luben RN, Bhaniani A, Parry-Smith DJ, O'Connor L, Khawaja AP, Forouhi NG, Khaw KT; EPIC-Norfolk FFQ Study. A new tool for converting food frequency questionnaire data into nutrient and food group values: FETA research methods and availability. BMJ Open. 2014 Mar 27;4(3):e004503. doi: 10.1136/bmjopen-2013-004503.</citation>
    <PMID>24674997</PMID>
  </reference>
  <reference>
    <citation>Kamencic H, Lyon A, Paterson PG, Juurlink BH. Monochlorobimane fluorometric method to measure tissue glutathione. Anal Biochem. 2000 Nov 1;286(1):35-7.</citation>
    <PMID>11038270</PMID>
  </reference>
  <reference>
    <citation>Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ 2nd, Ischiropoulos H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med. 2012 Jan 1;52(1):1-6. doi: 10.1016/j.freeradbiomed.2011.09.030. Epub 2011 Oct 2. Review.</citation>
    <PMID>22027063</PMID>
  </reference>
  <reference>
    <citation>Ustundag B, Gungor S, Aygün AD, Turgut M, Yilmaz E. Oxidative status and serum leptin levels in obese prepubertal children. Cell Biochem Funct. 2007 Sep-Oct;25(5):479-83.</citation>
    <PMID>16874844</PMID>
  </reference>
  <reference>
    <citation>Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004 Dec;114(12):1752-61.</citation>
    <PMID>15599400</PMID>
  </reference>
  <reference>
    <citation>Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ; Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):434-9. Epub 2003 Jan 30.</citation>
    <PMID>12615693</PMID>
  </reference>
  <reference>
    <citation>Il'yasova D, Wang F, Spasojevic I, Base K, D'Agostino RB Jr, Wagenknecht LE. Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. Obesity (Silver Spring). 2012 Oct;20(10):2147-50. doi: 10.1038/oby.2012.170. Epub 2012 Jun 22.</citation>
    <PMID>22836686</PMID>
  </reference>
  <reference>
    <citation>Kobayashi H, Matsuda M, Fukuhara A, Komuro R, Shimomura I. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes. Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1326-34. doi: 10.1152/ajpendo.90921.2008. Epub 2009 Apr 14.</citation>
    <PMID>19366877</PMID>
  </reference>
  <reference>
    <citation>Tormos KV, Anso E, Hamanaka RB, Eisenbart J, Joseph J, Kalyanaraman B, Chandel NS. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab. 2011 Oct 5;14(4):537-44. doi: 10.1016/j.cmet.2011.08.007.</citation>
    <PMID>21982713</PMID>
  </reference>
  <reference>
    <citation>Won HY, Sohn JH, Min HJ, Lee K, Woo HA, Ho YS, Park JW, Rhee SG, Hwang ES. Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development. Antioxid Redox Signal. 2010 Sep 1;13(5):575-87. doi: 10.1089/ars.2009.2989.</citation>
    <PMID>20367278</PMID>
  </reference>
  <reference>
    <citation>Bozinovski S, Seow HJ, Crack PJ, Anderson GP, Vlahos R. Glutathione peroxidase-1 primes pro-inflammatory cytokine production after LPS challenge in vivo. PLoS One. 2012;7(3):e33172. doi: 10.1371/journal.pone.0033172. Epub 2012 Mar 6.</citation>
    <PMID>22412999</PMID>
  </reference>
  <reference>
    <citation>Picklo MJ, Long EK, Vomhof-DeKrey EE. Glutathionyl systems and metabolic dysfunction in obesity. Nutr Rev. 2015 Dec;73(12):858-68. doi: 10.1093/nutrit/nuv042. Epub 2015 Oct 22. Review.</citation>
    <PMID>26493322</PMID>
  </reference>
  <reference>
    <citation>Setayesh T, Mišík M, Langie SAS, Godschalk R, Waldherr M, Bauer T, Leitner S, Bichler C, Prager G, Krupitza G, Haslberger A, Knasmüller S. Impact of Weight Loss Strategies on Obesity-Induced DNA Damage. Mol Nutr Food Res. 2019 Sep;63(17):e1900045. doi: 10.1002/mnfr.201900045. Epub 2019 Jun 14.</citation>
    <PMID>31141317</PMID>
  </reference>
  <reference>
    <citation>Santovito A, Gendusa C. Micronuclei frequency in peripheral blood lymphocytes of healthy subjects living in turin (North-Italy): contribution of body mass index, age and sex. Ann Hum Biol. 2020 Feb;47(1):48-54. doi: 10.1080/03014460.2020.1714728. Epub 2020 Jan 23.</citation>
    <PMID>31969023</PMID>
  </reference>
  <reference>
    <citation>Donmez-Altuntas H, Sahin F, Bayram F, Bitgen N, Mert M, Guclu K, Hamurcu Z, Arıbas S, Gundogan K, Diri H. Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects. Mutat Res Genet Toxicol Environ Mutagen. 2014 Sep 1;771:30-6. doi: 10.1016/j.mrgentox.2014.06.006. Epub 2014 Jun 28.</citation>
    <PMID>25308439</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 14, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 14, 2021</last_update_submitted>
  <last_update_submitted_qc>September 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Very low calorie diet</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Micronuclei</keyword>
  <keyword>apoptosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

